Literature DB >> 25846005

Structural analysis of the polo-box domain of human Polo-like kinase 2.

Ju Hee Kim1, Bonsu Ku1, Kyung S Lee2, Seung Jun Kim1.   

Abstract

Polo-like kinases (Plks) are the key regulators of cell cycle progression, the members of which share a kinase domain and a polo-box domain (PBD) that serves as a protein-binding module. While Plk1 is a promising target for antitumor therapy, Plk2 is regarded as a tumor suppressor even though the two Plks commonly recognize the S-pS/T-P motif through their PBD. Herein, we report the crystal structure of the PBD of Plk2 at 2.7 Å. Despite the overall structural similarity with that of Plk1 reflecting their high sequence homology, the crystal structure also contains its own features including the highly ordered loop connecting two subdomains and the absence of 310 -helices in the N-terminal region unlike the PBD of Plk1. Based on the three-dimensional structure, we furthermore could model its interaction with two types of phosphopeptides, one of which was previously screened as the optimal peptide for the PBD of Plk2.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Polo-like kinase 2; cell cycle; polo-box domain; structure; tumor suppressor

Mesh:

Substances:

Year:  2015        PMID: 25846005      PMCID: PMC7720676          DOI: 10.1002/prot.24804

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  37 in total

Review 1.  Structure and function of Polo-like kinases.

Authors:  Drew M Lowery; Daniel Lim; Michael B Yaffe
Journal:  Oncogene       Date:  2005-01-10       Impact factor: 9.867

Review 2.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.

Authors:  Klaus Strebhardt
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

Review 3.  Polo-box domain: a versatile mediator of polo-like kinase function.

Authors:  Jung-Eun Park; Nak-Kyun Soung; Yoshikazu Johmura; Young H Kang; Chenzhong Liao; Kyung H Lee; Chi Hoon Park; Marc C Nicklaus; Kyung S Lee
Journal:  Cell Mol Life Sci       Date:  2010-02-11       Impact factor: 9.261

4.  Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates.

Authors:  Andrew E H Elia; Lewis C Cantley; Michael B Yaffe
Journal:  Science       Date:  2003-02-21       Impact factor: 47.728

5.  Development of cyclic peptomer inhibitors targeting the polo-box domain of polo-like kinase 1.

Authors:  Ravichandran N Murugan; Jung-Eun Park; Dan Lim; Mija Ahn; Chaejoon Cheong; Taeho Kwon; Ky-Youb Nam; Sun Ho Choi; Bo Yeon Kim; Do-Young Yoon; Michael B Yaffe; Dae-Yeul Yu; Kyung S Lee; Jeong Kyu Bang
Journal:  Bioorg Med Chem       Date:  2013-02-27       Impact factor: 3.641

6.  Functional whole-genome analysis identifies Polo-like kinase 2 and poliovirus receptor as essential for neuronal differentiation upstream of the negative regulator alphaB-crystallin.

Authors:  Cristina Draghetti; Catherine Salvat; Francisca Zanoguera; Marie-Laure Curchod; Chloé Vignaud; Helene Peixoto; Alessandro Di Cara; David Fischer; Mohanraj Dhanabal; Goutopoulos Andreas; Hadi Abderrahim; Christian Rommel; Montserrat Camps
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

7.  Replication stress, defective S-phase checkpoint and increased death in Plk2-deficient human cancer cells.

Authors:  Elizabeth M Matthew; Timothy J Yen; David T Dicker; Jay F Dorsey; Wensheng Yang; Arunasalam Navaraj; Wafik S El-Deiry
Journal:  Cell Cycle       Date:  2007-09-25       Impact factor: 4.534

8.  The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain.

Authors:  Andrew E H Elia; Peter Rellos; Lesley F Haire; Jerry W Chao; Frank J Ivins; Katja Hoepker; Duaa Mohammad; Lewis C Cantley; Stephen J Smerdon; Michael B Yaffe
Journal:  Cell       Date:  2003-10-03       Impact factor: 41.582

9.  Exploring the binding nature of pyrrolidine pocket-dependent interactions in the polo-box domain of polo-like kinase 1.

Authors:  Ravichandran N Murugan; Mija Ahn; Woo Cheol Lee; Hye-Yeon Kim; Jung Hyun Song; Chaejoon Cheong; Eunha Hwang; Ji-Hyung Seo; Song Yub Shin; Sun Ho Choi; Jung-Eun Park; Jeong Kyu Bang
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

10.  Molecular basis for unidirectional scaffold switching of human Plk4 in centriole biogenesis.

Authors:  Suk-Youl Park; Jung-Eun Park; Tae-Sung Kim; Ju Hee Kim; Mi-Jeong Kwak; Bonsu Ku; Lan Tian; Ravichandran N Murugan; Mija Ahn; Shinobu Komiya; Hironobu Hojo; Nam-Hyung Kim; Bo Yeon Kim; Jeong K Bang; Raymond L Erikson; Ki Won Lee; Seung Jun Kim; Byung-Ha Oh; Wei Yang; Kyung S Lee
Journal:  Nat Struct Mol Biol       Date:  2014-06-29       Impact factor: 15.369

View more
  5 in total

Review 1.  Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy.

Authors:  Kyung S Lee; Terrence R Burke; Jung-Eun Park; Jeong K Bang; Eunhye Lee
Journal:  Trends Pharmacol Sci       Date:  2015-10-17       Impact factor: 14.819

2.  Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides.

Authors:  Xue Zhi Zhao; David Hymel; Terrence R Burke
Journal:  Bioorg Med Chem       Date:  2017-02-28       Impact factor: 3.641

3.  Plk2-mediated phosphorylation and translocalization of Nrf2 activates anti-inflammation through p53/Plk2/p21cip1 signaling in acute kidney injury.

Authors:  Da-Eun Kim; Hye Eun Byeon; Dae-Hoon Kim; Sang Geon Kim; Hyungshin Yim
Journal:  Cell Biol Toxicol       Date:  2022-07-16       Impact factor: 6.819

4.  Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling.

Authors:  Elizabeth M Matthew; Zhaohai Yang; Suraj Peri; Mark Andrake; Roland Dunbrack; Eric Ross; Wafik S El-Deiry
Journal:  Neoplasia       Date:  2018-02-12       Impact factor: 5.715

Review 5.  Polo-Like Kinase 2: From Principle to Practice.

Authors:  Chuanyong Zhang; Chuangye Ni; Hao Lu
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.